Pharming Group NV - ADRPHAR
13F holders, Q2 2025 (June 30)4holders
1new positions
1sold out
$10.69avg. 13F price*
At the end of Q2 2025, 4 institutions reported holding Pharming Group NV - ADR (PHAR) in their 13F filings, unchanged from Q1 2025. 1 opened new positions and 1 sold out. The largest holders were Silverberg Bernstein Capital Management LLC ($557K), EverSource Wealth Advisors, LLC ($32K) and Morgan Stanley ($31K).
- Company
- Pharming Group NV - ADR
- CUSIP
- 71716E105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $32K |
| Exits | 1 | $887 |
All 13F filers, Q1 2025 → Q2 2025: 7,129 shares bought and 106 shares sold, net +7,023 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Silverberg Bernstein Capital Management LLC | 0.38% | Add +8.7% | 52,147 | $557K |
| EverSource Wealth Advisors, LLC | 0.00% | New | 2,979 | $32K |
| Morgan Stanley | 0.00% | No change | 2,900 | $31K |
| Nalls Sherbakoff Group, LLC | 0.01% | No change | 870 | $9K |
"% of holder's portfolio" is PHAR's weight in each manager's 13F, not the share of Pharming Group NV - ADR the manager owns.